J Cosmet Med 2023; 7(1): 42-44
Published online June 30, 2023
Cheuk Hung Lee , MBBS (HK), FHKAM (MED), FHKCP, MScPD (Cardiff), MRCP (UK), DPD (Wales), DipDerm (Glasgow), PGDipClinDerm (London), MRCP (London), GradDipDerm (NUS), DipMed (CUHK), Kar Wai Alvin Lee , MBChB (CUHK), DCH (Sydney), Dip Derm (Glasgow), MScClinDerm (Cardiff), MScPD (Cardiff), DipMed (CUHK), DCH (Sydney), Kwin Wah Chan , MBChB (CUHK), MScPD (Cardiff), PgDipPD (Cardiff), PGDipClinDerm (Lond), DipMed (CUHK), DCH (Sydney)
Ever Keen Medical Centre, Hong Kong
Correspondence to :
Kar Wai Alvin Lee
E-mail: alvin429@yahoo.com
© Korean Society of Korean Cosmetic Surgery & Medicine
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Erythematotelangiectatic rosacea is a common, longstanding inflammatory skin disorder with unclear origin. It is characterized by facial erythema involving mainly the central face (malar areas, the chin, nasal area and forehead region) with a range of clinical presentations varying from hyperactivity of the blood vessels to sebaceous gland hyperplasia. It can lead to considerable psychosocial impact. Intense pulsed light (IPL) treatment can potentially have dramatic results on severe erythematotelangiectatic Rosacea. This is a case report of treating severe erythematotelangiectatic rosacea with IPL treatment. Pre-treatment and post-treatment clinical photos were provided to show the effect of IPL therapy on severe erythematotelangiectatic rosacea. This article is a case report together with literature review to explore the view of researchers on erythematotelangiectatic rosacea with IPL. No comparison is made with other treatment modalities. Nevertheless, it provides an alternative treatment option for patients with severe erythematotelangiectatic rosacea. Our case report shows that IPL at certain energy levels using multiple filters, can effectively treat severe erythematotelangiectatic rosacea. We believe with more treatment sessions patient can enjoy longer and persistent result. IPL is an effective treatment for erythematotelangiectatic rosacea. However, more erythematotelangiectatic rosacea cases treating with IPL will be required to consolidate IPL as one of the best treatment options in treating erythematotelangiectatic rosacea. Potential complications with IPL include post-inflammatory hyperpigmentation, burn and pain.
Keywords: intense pulsed light therapy, phototherapy, pigmentation disorders, rosacea
Vitiligo is an acquired cutaneous depigmentary disorder with a classical presentation of numerous or solitary well-defined depigmented patches or macules that can be localized, segmental, or non-segmental/generalized [1]. It affects approximately 0.1% to 3% of the population [2]. Its pathogenesis is not well understood; however, biochemical, neural, viral, genetic, and autoimmune causes have been proposed [3]. Vitiligo can cause psychosocial distress owing to the resulting cosmetic disfigurement, although it is not a detrimental disease.
Patient was a 46-year-old male Chinese accountant who visited my clinic presenting with a few white patches on his face for 2 years. The first lesion appeared on his forehead, and it was an irregular, tiny, whitish area. Later, it grew in size and spread to both sides of his face and to the right perioral area. The oral mucosa, legs, arms, body, and neck were not affected. These lesions were neither painless nor itchy. Patient’s biggest concern was facial disfigurement, which resulted in considerable stress during social activities. He felt embarrassed when people looked at him during conversations, and this negatively impacted his ability to enjoy social gatherings, including those with family members.
Patient had no known drug allergies and a good health history. No family history of thyroid disease, diabetes mellitus, or any other autoimmune diseases was present. He was not on any herbal or non-herbal supplements or drugs, and he was a non-drinker and non-smoker. As for his personal life, he had been living in his own property and had gotten divorced 1 year prior to the skin depigmentation. No significant mood changes were observed. His usual activities were indoor, and he did apply sunscreen when going outdoors.
Patient was diagnosed with vitiligo on his first visit to another family practice clinic. Topical steroid cream was prescribed, which he applied for only 4 days before discontinuation as a result of his friends indicating the side effects of steroids such as thinning of skin. He visited another clinic, and the family doctor suggested depigmentation. Patient did not follow this suggestion, as strict sun avoidance was difficult. In addition, owing to the potential side effects of psoralen with ultraviolet A treatment, he was reluctant to undergo phototherapy. He also refused oral medications owing to their side effects.
On physical examination, patient had Fitzpatrick type IV skin. More than 10 depigmented and well-defined macules and patches were observed on both sides of his face and his forehead (Fig. 1; we received the patient’s consent form about publishing all photographic materials). Owing to the patient’s request, photographs of other parts of his face have not been included. Scaling was not observed, and the oral mucosal area was not involved. No acanthosis nigricans, joint swelling, butterfly rashes, pallor, or goiters were observed. The nails, hair, and scalp were normal. No other similar lesions were observed in any other body parts. Patient did not show any signs of mood disorders.
A Wood’s lamp was used to examine the hypopigmented lesions. They appeared well-defined with a sharp border. This finding supported the diagnosis of acrofacial vitiligo. I also performed the following blood tests for patient owing to the association of vitiligo with other autoimmune diseases: renal, liver, and thyroid (free thyroxine and thyroid stimulating hormone) function tests, fasting glucose (to rule out diabetes mellitus) and anti-nuclear antibody levels, and complete blood count (to rule out pernicious anemia). All blood test results were normal.
The patient was unwilling to take any oral or topical medication. Compliance was one of the main hurdles to overcome in this case; however, this was mitigated after he agreed to the application of light therapy. We treated the patient with intense pulsed light, once every 3 weeks. An eye shield was provided. The parameters of the intense pulsed light are shown in Fig. 2.
Fig. 3 shows patient’s forehead a month after 15 treatment sessions with intense pulsed light. He was satisfied with the treatment outcome. Re-pigmentation was observed from the lesion borders to the central area. Owing to financial concerns, patient discontinued his treatment after 15 treatment sessions with intense pulsed light.
Patients with vitiligo may experience social embarrassment, stigmatization, and distress. Mechri et al. [4] reported a higher risk of anxiety-depression disorders in patients with vitiligo. Alghamdi et al. [5] interviewed 924 Saudi Arabians in a study; one-third believed that vitiligo was infectious, and more than 54% were unwilling to marry a patient with vitiligo. In addition to treating the patient’s skin problem, we also taught our patient the camouflage technique to conceal the lesions using concealer. The patient’s self-confidence improved with this measure.
Post et al. [6], in their literature review of laser-and intense pulsed-light-induced vitiligo patches, demonstrated that intense pulsed light can induce vitiligo.
For light therapy of vitiligo, only the effectiveness of monochromatic excimer laser in re-pigmenting vitiligo lesions is supported by evidence [7]. Our case report provides a new treatment option for patients with vitiligo by demonstrating that intense pulsed light can be effective in treating them. We do not know the mechanism of action, but we hypothesize it is similar to that causing post-inflammatory hyperpigmentation, which is usually regarded as a side effect of light treatment.
In this case report, we demonstrate that intense pulsed light can help induce re-pigmentation in patients with vitiligo. More research is needed on histological changes in post-IPL tissue and for the evaluation of long-term sustainable results and optimal treatment parameters. Furthermore, selection of patients is also important. Potential complications with intense pulsed light include post-inflammatory hyperpigmentation, burns, and pain [8].
The authors have nothing to disclose.
J Cosmet Med 2023; 7(1): 42-44
Published online June 30, 2023 https://doi.org/10.25056/JCM.2023.7.1.42
Copyright © Korean Society of Korean Cosmetic Surgery & Medicine.
Cheuk Hung Lee , MBBS (HK), FHKAM (MED), FHKCP, MScPD (Cardiff), MRCP (UK), DPD (Wales), DipDerm (Glasgow), PGDipClinDerm (London), MRCP (London), GradDipDerm (NUS), DipMed (CUHK), Kar Wai Alvin Lee , MBChB (CUHK), DCH (Sydney), Dip Derm (Glasgow), MScClinDerm (Cardiff), MScPD (Cardiff), DipMed (CUHK), DCH (Sydney), Kwin Wah Chan , MBChB (CUHK), MScPD (Cardiff), PgDipPD (Cardiff), PGDipClinDerm (Lond), DipMed (CUHK), DCH (Sydney)
Ever Keen Medical Centre, Hong Kong
Correspondence to:Kar Wai Alvin Lee
E-mail: alvin429@yahoo.com
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Erythematotelangiectatic rosacea is a common, longstanding inflammatory skin disorder with unclear origin. It is characterized by facial erythema involving mainly the central face (malar areas, the chin, nasal area and forehead region) with a range of clinical presentations varying from hyperactivity of the blood vessels to sebaceous gland hyperplasia. It can lead to considerable psychosocial impact. Intense pulsed light (IPL) treatment can potentially have dramatic results on severe erythematotelangiectatic Rosacea. This is a case report of treating severe erythematotelangiectatic rosacea with IPL treatment. Pre-treatment and post-treatment clinical photos were provided to show the effect of IPL therapy on severe erythematotelangiectatic rosacea. This article is a case report together with literature review to explore the view of researchers on erythematotelangiectatic rosacea with IPL. No comparison is made with other treatment modalities. Nevertheless, it provides an alternative treatment option for patients with severe erythematotelangiectatic rosacea. Our case report shows that IPL at certain energy levels using multiple filters, can effectively treat severe erythematotelangiectatic rosacea. We believe with more treatment sessions patient can enjoy longer and persistent result. IPL is an effective treatment for erythematotelangiectatic rosacea. However, more erythematotelangiectatic rosacea cases treating with IPL will be required to consolidate IPL as one of the best treatment options in treating erythematotelangiectatic rosacea. Potential complications with IPL include post-inflammatory hyperpigmentation, burn and pain.
Keywords: intense pulsed light therapy, phototherapy, pigmentation disorders, rosacea
Vitiligo is an acquired cutaneous depigmentary disorder with a classical presentation of numerous or solitary well-defined depigmented patches or macules that can be localized, segmental, or non-segmental/generalized [1]. It affects approximately 0.1% to 3% of the population [2]. Its pathogenesis is not well understood; however, biochemical, neural, viral, genetic, and autoimmune causes have been proposed [3]. Vitiligo can cause psychosocial distress owing to the resulting cosmetic disfigurement, although it is not a detrimental disease.
Patient was a 46-year-old male Chinese accountant who visited my clinic presenting with a few white patches on his face for 2 years. The first lesion appeared on his forehead, and it was an irregular, tiny, whitish area. Later, it grew in size and spread to both sides of his face and to the right perioral area. The oral mucosa, legs, arms, body, and neck were not affected. These lesions were neither painless nor itchy. Patient’s biggest concern was facial disfigurement, which resulted in considerable stress during social activities. He felt embarrassed when people looked at him during conversations, and this negatively impacted his ability to enjoy social gatherings, including those with family members.
Patient had no known drug allergies and a good health history. No family history of thyroid disease, diabetes mellitus, or any other autoimmune diseases was present. He was not on any herbal or non-herbal supplements or drugs, and he was a non-drinker and non-smoker. As for his personal life, he had been living in his own property and had gotten divorced 1 year prior to the skin depigmentation. No significant mood changes were observed. His usual activities were indoor, and he did apply sunscreen when going outdoors.
Patient was diagnosed with vitiligo on his first visit to another family practice clinic. Topical steroid cream was prescribed, which he applied for only 4 days before discontinuation as a result of his friends indicating the side effects of steroids such as thinning of skin. He visited another clinic, and the family doctor suggested depigmentation. Patient did not follow this suggestion, as strict sun avoidance was difficult. In addition, owing to the potential side effects of psoralen with ultraviolet A treatment, he was reluctant to undergo phototherapy. He also refused oral medications owing to their side effects.
On physical examination, patient had Fitzpatrick type IV skin. More than 10 depigmented and well-defined macules and patches were observed on both sides of his face and his forehead (Fig. 1; we received the patient’s consent form about publishing all photographic materials). Owing to the patient’s request, photographs of other parts of his face have not been included. Scaling was not observed, and the oral mucosal area was not involved. No acanthosis nigricans, joint swelling, butterfly rashes, pallor, or goiters were observed. The nails, hair, and scalp were normal. No other similar lesions were observed in any other body parts. Patient did not show any signs of mood disorders.
A Wood’s lamp was used to examine the hypopigmented lesions. They appeared well-defined with a sharp border. This finding supported the diagnosis of acrofacial vitiligo. I also performed the following blood tests for patient owing to the association of vitiligo with other autoimmune diseases: renal, liver, and thyroid (free thyroxine and thyroid stimulating hormone) function tests, fasting glucose (to rule out diabetes mellitus) and anti-nuclear antibody levels, and complete blood count (to rule out pernicious anemia). All blood test results were normal.
The patient was unwilling to take any oral or topical medication. Compliance was one of the main hurdles to overcome in this case; however, this was mitigated after he agreed to the application of light therapy. We treated the patient with intense pulsed light, once every 3 weeks. An eye shield was provided. The parameters of the intense pulsed light are shown in Fig. 2.
Fig. 3 shows patient’s forehead a month after 15 treatment sessions with intense pulsed light. He was satisfied with the treatment outcome. Re-pigmentation was observed from the lesion borders to the central area. Owing to financial concerns, patient discontinued his treatment after 15 treatment sessions with intense pulsed light.
Patients with vitiligo may experience social embarrassment, stigmatization, and distress. Mechri et al. [4] reported a higher risk of anxiety-depression disorders in patients with vitiligo. Alghamdi et al. [5] interviewed 924 Saudi Arabians in a study; one-third believed that vitiligo was infectious, and more than 54% were unwilling to marry a patient with vitiligo. In addition to treating the patient’s skin problem, we also taught our patient the camouflage technique to conceal the lesions using concealer. The patient’s self-confidence improved with this measure.
Post et al. [6], in their literature review of laser-and intense pulsed-light-induced vitiligo patches, demonstrated that intense pulsed light can induce vitiligo.
For light therapy of vitiligo, only the effectiveness of monochromatic excimer laser in re-pigmenting vitiligo lesions is supported by evidence [7]. Our case report provides a new treatment option for patients with vitiligo by demonstrating that intense pulsed light can be effective in treating them. We do not know the mechanism of action, but we hypothesize it is similar to that causing post-inflammatory hyperpigmentation, which is usually regarded as a side effect of light treatment.
In this case report, we demonstrate that intense pulsed light can help induce re-pigmentation in patients with vitiligo. More research is needed on histological changes in post-IPL tissue and for the evaluation of long-term sustainable results and optimal treatment parameters. Furthermore, selection of patients is also important. Potential complications with intense pulsed light include post-inflammatory hyperpigmentation, burns, and pain [8].
The authors have nothing to disclose.
Cheuk Hung Lee, MBBS (HK), FHKAM (MED), FHKCP, MScPD (Cardiff), MRCP (UK), DPD (Wales), DipDerm (Glasgow), PGDipClinDerm (London), MRCP (London), GradDipDerm (NUS), DipMed (CUHK), Kar Wai Alvin Lee, MBChB (CUHK), DCH (Sydney), Dip Derm (Glasgow), MScClinDerm (Cardiff), MScPD (Cardiff), DipMed (CUHK), DCH (Sydney), Kwin Wah Chan, MBChB (CUHK), MScPD (Cardiff), PgDipPD (Cardiff), PGDipClinDerm (Lond), DipMed (CUHK), DCH (Sydney)
J Cosmet Med 2023; 7(1): 38-41 https://doi.org/10.25056/JCM.2023.7.1.38Cheuk Hung Lee, MBBS (HK), FHKAM (MED), FHKCP, MScPD (Cardiff), MRCP (UK), DPD (Wales), DipDerm (Glasgow), PGDipClinDerm (London), MRCP (London), GradDipDerm (NUS), DipMed (CUHK), Kar Wai Alvin Lee, MBChB (CUHK), DCH (Sydney), Dip Derm (Glasgow), MScClinDerm (Cardiff), MScPD (Cardiff), DipMed (CUHK), DCH (Sydney), Kwin Wah Chan, MBChB (CUHK), MScPD (Cardiff), PgDipPD (Cardiff), PGDipClinDerm (Lond), DipMed (CUHK), DCH (Sydney)
J Cosmet Med 2024; 8(1): 66-71 https://doi.org/10.25056/JCM.2024.8.1.66Cheuk Hung Lee, MBBS (HK), FHKAM (MED), FHKCP, MScPD (Cardiff), MRCP (UK), DPD (Wales), DipDerm (Glasgow), PGDipClinDerm (London), MRCP (London), GradDipDerm (NUS), DipMed (CUHK), Kar Wai Alvin Lee, MBChB (CUHK), DCH (Sydney), Dip Derm (Glasgow), MScClinDerm (Cardiff), MScPD (Cardiff), DipMed (CUHK), DCH (Sydney), Kwin Wah Chan, MBChB (CUHK), MScPD (Cardiff), PgDipPD (Cardiff), PGDipClinDerm (Lond), DipMed (CUHK), DCH (Sydney), Kar Wai Phoebe Lam, MBCHB (OTAGO), MRCS (EDIN), MSCPD (CARDIFF)
J Cosmet Med 2022; 6(2): 99-102 https://doi.org/10.25056/JCM.2022.6.2.99